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We read with interest the article by Chaouki, et al.
1
, exploring risk factors for neonatal and infant 
pacemaker implantation.  It is encouraging that their data support low morbidity in device implantation 
in patients >4kg and >21 days.  We question, however, the result and conclusion that patients <3kg and 
<5 days are in fact at greater risk regardless of device size.  We suggest that the driving force behind 
morbidity is device volume (more correctly, the total pocket volume, including the lead volume) to 
abdominal volume ratio, conferring greater abdominal wall stress.  While such a value in the author’s 
data set would likely reveal unchanged results, this is likely due to their cohort’s lack of device volume 
variation.  The mean volume described was 11.1 cm
3
 with an interquartile range of 10.8 cm
3
 – 11.1 cm
3
.  
If pacemakers smaller than those described did not exist, the conclusions could be supported on such 
grounds.  While we are frustratingly limited by device choice in the newborn and infant patient 
population, smaller devices are, however, available including volumes as low as 5.9 cm
3
 for single 
chamber (introduced 1995)
2
 and 8.0 cm
3
 for dual chamber (introduced 2007)
3
.  Had these devices been 
represented in the cohort it would be more reasonable to conclude that “…device characteristics appear 
to play a minor role.”  It is somewhat similar to concluding that an athlete’s VO2 max plays a minor role 
in their ability to win a race if only athletes with VO2 max’s of 55 - 60 mL/(kg x min) are represented in a 
cohort.  With smaller devices included, I suspect that device characteristics would play a larger role and 
that patient complication odds ratios would be different for the patient sizes presented.  If true, limiting 
implantation to infants >3kg and >5 days of age would be unnecessarily stringent.  As described by the 
authors, further evaluation with current devices between multiple centers would provide a wonderful 
opportunity to assist in risk stratifying patients based on patient size and age relative to device size and 
number of leads, all of which impact total pocket volume to abdominal volume ratio. 
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